Inventisbio Co., Ltd

This study tests whether an experimental drug called D-2570 can help people with moderately to severely active ulcerative colitis achieve remission. About 120 adults will receive either D-2570 or a placebo daily for 12 weeks. The main goal is to see if more people on D-2570 reach…

This study tests a combination of two oral drugs, D-1553 and IN10018, in people with advanced or metastatic solid tumors that have a specific genetic change called KRasG12C. The goal is to see if the combination is safe, tolerable, and effective at shrinking tumors. Participants …

This early-phase trial is testing the safety and tolerability of a new drug called D-2570 in 36 healthy volunteers. Participants receive either the drug or a placebo, and researchers monitor side effects and how the drug moves through the body. Since this is a Phase 1 study in he…

This study uses a tiny amount of radioactive labeling to track how the experimental drug D-2570 moves through the body and is eliminated. Eight healthy Chinese men will provide blood, urine, and stool samples to measure the drug's breakdown and excretion. The goal is to understan…